SFMBT2 and cancer: Considering that circRNA dysregulation is responsible for the emergence of cancer drug resistance [29], a deeper understanding of whether circRNA-SFMBT2 mediates endocrine resistance development via interactions with transcription factors to manipulate intracellular signaling pathways is needed.